JMP Securities lifts Spectrum Pharmaceuticals Inc. [SPPI] price estimate. Who else is bullish?

Related

Spectrum Pharmaceuticals Inc. [NASDAQ: SPPI] loss -3.01% or -0.04 points to close at $1.29 with a heavy trading volume of 2437995 shares. The company report on December 22, 2021 that SHAREHOLDER ALERT: Robbins LLP Investigates Spectrum Pharmaceuticals, Inc. (SPPI) for Misleading Shareholders.

Shareholder rights law firm Robbins LLP is investigating Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to determine whether certain Spectrum officers and directors violated the Securities Exchange Act of 1934 and breached fiduciary duties to shareholders. Spectrum is a biopharmaceutical company that develops and commercializes oncology and hematology drug products. One product the Company has under development is ROLONTIS (eflapegrastim), a novel long-lasting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


If you would like more information about Spectrum Pharmaceuticals, Inc.’s misconduct, click here.

It opened the trading session at $1.36, the shares rose to $1.36 and dropped to $1.27, the range by which the price of stock traded the whole day. The daily chart for SPPI points out that the company has recorded -65.60% loss over the past six months. However, it is still 0.77% lower than its most recent low trading price.

If we look at the average trading volume of 3.92M shares, SPPI reached to a volume of 2437995 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Spectrum Pharmaceuticals Inc. [SPPI]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SPPI shares is $6.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SPPI stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

JMP Securities have made an estimate for Spectrum Pharmaceuticals Inc. shares, keeping their opinion on the stock as Mkt Outperform, with their previous recommendation back on September 17, 2020. The new note on the price target was released on December 26, 2019, representing the official price target for Spectrum Pharmaceuticals Inc. stock. Previously, the target price had yet another drop from $17 to $4, while Cantor Fitzgerald kept a Neutral rating on SPPI stock.

The Average True Range (ATR) for Spectrum Pharmaceuticals Inc. is set at 0.13 The Price to Book ratio for the last quarter was 2.58, with the Price to Cash per share for the same quarter was set at 0.83.

Trading performance analysis for SPPI stock

Spectrum Pharmaceuticals Inc. [SPPI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -14.00. With this latest performance, SPPI shares dropped by -18.35% in over the last four-week period, additionally sinking by -65.60% over the last 6 months – not to mention a drop of -61.83% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SPPI stock in for the last two-week period is set at 31.48, with the RSI for the last a single of trading hit 27.01, and the three-weeks RSI is set at 34.04 for Spectrum Pharmaceuticals Inc. [SPPI]. The present Moving Average for the last 50 days of trading for this stock 1.7548, while it was recorded at 1.4060 for the last single week of trading, and 2.7064 for the last 200 days.

Spectrum Pharmaceuticals Inc. [SPPI]: A deeper dive into fundamental analysis

Return on Total Capital for SPPI is now -102.52, given the latest momentum, and Return on Invested Capital for the company is -104.47. Return on Equity for this stock declined to -105.52, with Return on Assets sitting at -74.43. When it comes to the capital structure of this company, Spectrum Pharmaceuticals Inc. [SPPI] has a Total Debt to Total Equity ratio set at 1.81. Additionally, SPPI Total Debt to Total Capital is recorded at 1.78, with Total Debt to Total Assets ending up at 1.23. Long-Term Debt to Equity for the company is recorded at 0.66, with the Long-Term Debt to Total Capital now at 0.65.

Reflecting on the efficiency of the workforce at the company, Spectrum Pharmaceuticals Inc. [SPPI] managed to generate an average of -$973,136 per employee.Spectrum Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.40 and a Current Ratio set at 2.40.

>> 7 Top Picks for the Post-Pandemic Economy <<

An analysis of insider ownership at Spectrum Pharmaceuticals Inc. [SPPI]

There are presently around $140 million, or 66.00% of SPPI stock, in the hands of institutional investors. The top three institutional holders of SPPI stocks are: BLACKROCK INC. with ownership of 30,531,435, which is approximately 1.115% of the company’s market cap and around 0.20% of the total institutional ownership; STATE STREET CORP, holding 17,136,619 shares of the stock with an approximate value of $22.79 million in SPPI stocks shares; and ARMISTICE CAPITAL, LLC, currently with $21.81 million in SPPI stock with ownership of nearly 48.443% of the company’s market capitalization.

Positions in Spectrum Pharmaceuticals Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 65 institutional holders increased their position in Spectrum Pharmaceuticals Inc. [NASDAQ:SPPI] by around 14,811,310 shares. Additionally, 73 investors decreased positions by around 13,333,546 shares, while 36 investors held positions by with 77,234,524 shares. The mentioned changes placed institutional holdings at 105,379,380 shares, according to the latest SEC report filing. SPPI stock had 18 new institutional investments in for a total of 646,874 shares, while 25 institutional investors sold positions of 1,839,892 shares during the same period.